MENLO PARK, Calif., Sept. 10, 2019 /PRNewswire/ -- Ablacon, Inc. (www.ablacon.com), an Ajax Health-funded company, announced today the release of an updated version of its Ablamap technology under the company's existing CE Mark. The new update includes an enhanced physician experience and...
Ablacon is a Colorado-based AI firm that designs and develops an atrial fibrillation system to analyze and visualize electrographic flow within the cardiac chambers.